Novelties In Diabetes

The field of diabetes mellitus research is currently characterized by rapid and remarkable growth that has led to the development of significant diagnostic and therapeutic advances. This is very important given the fact that the frequency of the disease continues to increase at alarming rates worldwide. This new volume is a comprehensive overview of the contemporary state of the art in the field. Experts shed light on a broad range of relevant aspects, from genetic background to topics related to diabetic complications such as diabetic retinopathy or diabetic nephropathy. This is expanded upon through papers reporting on the present state of diabetes in pregnancy and on the relationship between diabetes and cancer. There is also an inventory of currently used therapeutic tools and a review of novel therapeutic approaches like incretin-based therapies or sodium-glucose transporter-2 inhibitors. Additionally, the latest technological developments such as enhanced features for blood glucose meter or continuous and implantable glucose monitoring devices are included. Providing a concise but comprehensive update, this book will be essential to every clinician involved in the treatment of diabetes mellitus.

Diabetes has become a worldwide health problem, the global estimated prevalence approaches ten percent and the burden of this disease in terms of morbidity and mortality is unprecedented. The advances acquired through the knowledge of the mechanisms of the disease and the variety of therapeutic approaches contrast with the inability of private and public health systems in underdeveloped and even developed countries to achieve the goals of treatment. This paradox has been described in many sources: the surge of scientific advances contrast with an unprecedented amount of human suffering. Thus, a patient centered and an evidence based approach with the capacity to produce measurable clinical and economic outcomes is required. The purpose of this textbook is multiple: to offer a comprehensive resource covering all aspects of outpatient management; to address diabetes as a health problem from an epidemiological, economic and clinical perspective; to discuss the role of social determinants of health on the worldwide increase in diabetes; to highlight the challenges and obstacles in providing adequate care; and to outline a multidisciplinary approach to management in which medical visits retain their importance as part of a team comprising the patient, his or her family and a multidisciplinary group of health professionals who are able to move beyond the traditional approach of diabetes as a disease and greatly improve outcomes.

Diabetes Management in Primary Care, 2nd Edition serves as an evidence-based guide for primary care physicians, residents, and medical students in managing patients with diabetes. This text covers all aspects of outpatient care for adults and adolescents with diabetes. You’ll find comprehensive coverage of the latest therapeutic, behavioral, and surgical options to successfully manage diabetic patients within the primary care setting. Diabetes Management in Primary Care is based upon patient centered strategies and customized care. Whether the patient has prediabetes or advanced long-term complications such as retinopathy or chronic kidney disease, providers of all specialties and all levels of care will gain insight into safe, effective and rationale intensification of one’s care. Complex co-existing disorders such as cancer, severe clinical obesity, polycystic ovary syndrome, severe insulin resistance, hypoglycemia awareness autonomic failure, steroid induced hyperglycemia and sleep disorders are discussed in vibrant detail. Diabetes Management in Primary Care is the first medical text book to address many of the topics listed below. One of the most anticipated chapters discusses the importance of incorporating cultural diversity into one’s treatment plan. New to this edition: · Access to the companion website that includes the fully searchable text for quick reference · ADA/IDF screening algorithms included to allow for faster determinations · Discussion of new agents for Type II diabetes to keep you updated on the most recent therapies available, including new long acting basal insulin and incretin mimetics and drugs in the R and D pipeline. · Questions that patients want answered including: “When will diabetes be cured?” · Examination of the relationship between obesity, sleep disorder and diabetes · Detailed discussion of the relationship between cancer and diabetes · The importance of becoming a culturally diverse clinician · The politics of diabetes management in the US · Updated guidelines for the diagnosis and management of polycystic ovary syndrome · Useful forms to streamline and document practice including: patient history, physical exam, complication surveillance, laboratory tests, and diabetes patient education This is the tablet version which does not include access to the supplemental content mentioned in the text.

"Caring for diabetes in children and adolescents is a challenging task for families and their health professionals. Education and knowledge are essential elements in being able to look after your child’s diabetes from day to day and in special situations. This resource aims to provide this information for you. It will help you revise and build on your knowledge from your diabetes education and also serve as a ready reference when new situations arise."--Publisher's website.

In a normal physiological state, several bacteria are present in the human gut that is essential to maintain the normal to healthy gastrointestinal function. Disturbances in this “normal flora” lead to gut inflammation and infection. This volume explores the potential of probiotics, the healthy bacteria, to manage gut-related diseases including gastrointestinal cancers, ulcerative colitis, H. pylori infections, and diarrhea; vaginosis; oral health; airway inflammation; and atopic dermatitis. The concept of designer probiotics, edible vaccines and future scope of research in the field is also presented. The animal models used for studying the benefits of probiotics in gut inflammation are described for beginners.

This book contains the latest research work presented at the International Conference on Computing and Communication Systems (I3CS 2020) held at North-Eastern Hill University (NEHU), Shillong, India. The book presents original research results, new ideas and practical development experiences which concentrate on both theory and practices. It includes papers from all areas of information technology, computer science, electronics and communication engineering written by researchers, scientists, engineers and scholar students and experts from India and abroad.

A history of diabetology told by renowned contributors, many have themselves already become a part of diabetes history. A must-have for every diabetologist! Diabetologists, diabetes educators, and many interested readers will appreciate this book. What is more, countless celebrations are planned for the 100th anniversary of the discovery of insulin: this book provides numerous illustrations, accounts of personal experiences, and critical remarks on the history of diabetology – in addition to the history of insulin. It spans an arc from antiquity to the work of Claude Bernard, Paul Langerhans, Josef von Mering, Apollinaire Bouchardat, Oskar Minkowski, E.P. Joslin, and F.M. Allen. The history of insulin is presented from the perspective of diabetologists from Scotland, Spain, Germany, and Poland. The history of oral antidiabetics is told by Harald Lebovitz, and the chapter about glitazones by Edwin Gale reads like a spy novel! Pierre Lefèbvre describes the work of the diabetologist Jean Pirart and the history of glucagon. Sir George Alberti has provided a chapter about the therapy of ketoacidosis, to which he himself made groundbreaking contributions. Nephropathy is presented by Hans-Henrik Parving, and Eva Kohner, Ronald Klein and Barbara E.K. Klein have contributed a chapter on retinopathy. Other contemporary topics such diabetes in pregnancy, diabetes technology, psychosocial aspects of diabetes, and the history of the EASD and ADA are also included in this book.

Diabetic retinopathy is the most common microvascular complication of diabetes. It remains a major cause of new-onset visual loss in the United States and other industrialized nations. In Diabetic Retinopathy, Elia Duh and a panel of internationally recognized experts comprehensively assess the current state of knowledge regarding the clinical management of DR as well as its underlying mechanisms. The authors outline the current understanding of diabetic retinopathy from the perspective of clinical practice, while reviewing the multi-factorial pathogenesis and pathophysiology of DR from the standpoint of biomedical research. Also included is a discussion of emerging concepts relating to the management and treatment of DR. Informative and highly-practical, Diabetic Retinopathy provides ophthalmologists, diabetologists, endocrinologists, and internists with a highly readable guide not only to understanding diabetic retinopathy, but also to its optimal clinical management.